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Environmental stressHuntington's Disease is a neurodegenerative condition caused by a polyglutamine expansion in the
huntingtin (Htt) protein, which aggregates and also causes neuronal dysfunction. Pathogenic N-terminal htt
fragments perturb axonal transport in vitro. To determine whether this occurs in vivo and to elucidate how
transport is affected, we expressed htt exon 1 with either pathogenic (HttEx1Q93) or non-pathogenic
(HttEx1Q20) polyglutamine tracts in Drosophila. We found that HttEx1Q93 expression causes axonal
accumulation of GFP-tagged fast axonal transport vesicles in vivo and leads to aggregates within larval motor
neuron axons. Time-lapse video microscopy, shows that vesicle velocity is unchanged in HttEx1Q93-axons
compared to HttEx1Q20-axons, but vesicle stalling occurs to a greater extent. Whilst HttEx1Q93 expression
did not affect locomotor behaviour, external heat stress unveiled a locomotion deﬁcit in HttEx1Q93 larvae.
Therefore vesicle transport abnormalities amidst axonal htt aggregation places a cumulative burden upon
normal neuronal function under stressful conditions.
© 2009 Elsevier Inc. All rights reserved.Introduction
Neurodegeneration in Huntington's Disease (HD), caused by an
N-terminal polyglutamine (polyQ) expansion within the huntingtin
(Htt) protein (TheHuntington's Disease Collaborative Research Group,
1993), involves progressive death of neurons in the striatum and
cortex (Reiner et al., 1988). As clinical progression can precede
extensive neuronal death (Vonsattel et al., 1985), focus has centred
on early pathological events that disrupt neuronal function prior to
neuronal demise. Axonal dysfunctionmay represent one such event, as
post mortem brain tissue from pre-symptomatic HD sufferers exhibits
axonal degeneration of striatal projection neurons (Albin et al., 1992)
and cortico-striatal afferents (Sapp et al., 1999). Dystrophic neurites,
and swellings of accumulated cargoes indicative of axonal transport
disruption, have been localised to aggregated htt inclusion bodies, a.mudher@soton.ac.uk
irect.com).
l rights reserved.(IBs), a common biomarker for HD neuropathology (DiFiglia et al.,
1997). Axonal abnormalities have also been described in pre-
symptomatic HD mice expressing the ﬁrst exon of htt (HttEx1) with
a polyQ expansion (Wade et al., 2008). Analysis of pathogenic human
htt effects on axonal transport in transgenic animal models (Li et al.,
2001; Gunawardena et al., 2003; Lee et al., 2004; Trushina et al., 2004)
demonstrates that a functional htt deﬁcit and its aggregation into
axonal IBs, which impede transport and sequester motor components,
may be key pathogenic events. Whilst end-point indications of axonal
transport disruption are intriguing, dynamic events underlying per-
turbation have, to date, only been assessed in vitro (Szebenyi et al.,
2003; Trushina et al., 2004; Orr et al., 2008), prompting the develop-
ment of animal models to analyse such phenomena in a less
biologically artiﬁcial environment in vivo.
Transgenic expression of pathogenic HttEx1 induces HD-like patho-
logy in mice (Mangiarini et al., 1996) and neurotoxicity in Drosophila
(Steffan et al., 2001). Furthermore pan-neuronal expression of polyQ-
expanded HttEx1 in Drosophila induces the accumulation of axonal
transport cargoes within motor and sensory axons of the major larval
peripheral nerves ex vivo (Gunawardena et al., 2003). Whilst previous
work has utilised thepliable genetics ofDrosophila to further understand
Fig. 1. Axonal Htt distribution and aggregation in Drosophila motor neuron axons. (A)
Representative structures detected with anti-HttEx1 (S830) and anti-Htt aggregate
(EM48) antibodies in larvae expressing HttEx1-polyQ in motor neurons. S830 (i)
annular or (ii) dense large aggregate (LAg); (iii) small aggregate (SAg); (iv) track (TR);
(v) EM48 large aggregate (LAg). The typical distribution of HttEx1, detected with S830,
in wild-type OreR, HttEx1Q20 and pathological HttEx1Q93 axons is shown for animals
raised at 23 °C (B) and 29 °C (F). 5 larvae were analysed for each genotype. Typical Htt
EM48 aggregate immunoreactivity for animals raised at 23 °C (D) and 29 °C (H) is also
shown. Q93 animals raised at 23 °C possess more LAg than controls (E). This trait is
exacerbated in Q93 animals raised at 29 °C (I), in which SAg and TRs are also elevated.
Q93 larvae raised at 23 °C display more EM48 SAg than controls (E), whereas animals
raised at 29 °C display fewer SAg but more LAg (I). For each genotype, 4 larvae raised at
23 °C and 3 raised at 29 °C were analysed. Statistically signiﬁcant differences for
relevant comparisons are indicated by stars ⁎pb0.05; ⁎⁎pb0.01; ⁎⁎⁎pb0.001. Non-
signiﬁcance is not indicated. Scale bars are 3 μm (A) and 5 μm (B, D, F and H).
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transport motors (Gunawardena et al., 2003), mutant htt transport
perturbation remains unconﬁrmed in live animals and dynamic events
occurring prior to cargo accumulation have yet to be probed directly.
Here, we describe a newmodel of mutant HttEx1 axonal pathology
in which both expanded HttEx1 and a ﬂuorescent axonal transport
reporter protein are expressed speciﬁcally in Drosophila motor
neurons, and result in somal and axonal HttEx1 aggregation. Real-
time axonal vesicle stalling and cargo accumulation is observed in live,
intact larvae for the ﬁrst time in an HD animal model. By assaying the
consequences of mutant htt expression for larval behaviour we show
that transgenic larvae move normally but exhibit a marked locomotor
deﬁcit following additional external heat stress. This model will
contribute towards an understanding of pathological axonal transport
events arising due to an interplay between N-terminal htt toxicity and
environmental stressors in HD.
Results
Mutant HttExon1 aggregates within Drosophila motor neuron axons
To understand the effects of pathogenic htt on axonal transport, a
human HttEx1 fragment comprising of 63 N-terminal amino acids,
ﬂanking a non-pathogenic (HttEx1Q20) or pathogenic length
(HttEx1Q93) polyQ tract (Steffan et al., 2001), was expressed in Dro-
sophila motor neurons with the D42-GAL4 driver. N-terminal htt,
consistent with the size of HttEx1, is cleaved during HD pathology and
found in HD inclusion bodies (IBs) in human brain (Zhou et al., 2003).
As axonal mutant HttEx1 aggregates may contribute to transport
disruption (Gunawardena et al., 2003), we studied the axonal
distribution of HttEx1 in ﬁxed motor neuron axons within the
peripheral nerves of dissected larvae. Immunohistochemistry with
the S830 antibody, directed at the N-terminus of human htt
(Sathasivam et al., 2001), reveals characteristic HttEx1 accumulation
in the nerves of HttEx1Q20 and HttEx1Q93 larvae raised at 23 °C that
is absent in Oregon R (OreR) wild-type controls (Figs. 1 A, B). Staining
is not observed upon omission of primary antibodies (Fig. S1). Annular
(Fig. 1Ai) or spherical (Fig. 1Aii) aggregates of HttEx1 that exceed
1.3 μm in diameter, classed as large aggregates (LAg), are present in
larval nerve in this model (Figs. 1A–E; Fig. S2) (refer to materials and
methods for further details on classiﬁcation of aggregates). LAg are
signiﬁcantly elevated in HttEx1Q93 larvae raised at 23 °C relative to
OreR (Fig. 1B, C, pb0.05, n=5) and there is a trend towards increased
LAg in HttEx1Q93 versus HttEx1Q20 (Fig. 1C, p=0.13). Small
aggregates (SAg) with a diameter below 1.3 μm (Fig. 1Aiii), or tracks
(TRs) that appear to run along a single axon (Fig.1Aiv), are unchanged
in HttEx1Q93 larvae relative to HttEx1Q20 (Fig. 1C). EM48 antibody,
which reacts with HttEx1 and is relatively selective towards
aggregated htt species (Zhou et al., 2003), reveals a signiﬁcantly
greater number of SAg structures in HttEx1Q93 nerves (Figs. 1D, E,
pb0.001, n=4), although LAg are rare (Fig. 1E). HttEx1 aggregate-like
structures thus form within the nerves of HttEx1Q20/Q93 larvae
detected with two different antibodies, with an increase of SAg in
mutant larvae detected by the EM48 antibody.
As UAS-GAL4 transgene expression can be temperature-sensitive
(Phelps and Brand, 1998), HttEx1Q93 larvae raised at 23 °C may
display moderate levels of htt aggregation due to low mutant
transgene expression levels. We thus investigated the effect of raising
larvae at 29 °C on the axonal distribution and expression levels of
HttEx1Q93. HttEx1Q93 larvae raised at 29 °C show a striking increase
in LAg, SAg and TR numbers, as detected with S830 antibody in
peripheral nerves, with all accumulate types signiﬁcantly more
prevalent compared to HttEx1Q20 controls (Figs. 1F, G, LAg pb0.001,
SAg pb0.01, TR pb0.01, n=5). When HttEx1Q93 larvae raised at 29 °C
are analysed with EM48 antibody (Fig. 1H), LAg are 8 times more
prevalent than in HttEx1Q20 (Fig. 1I, pb0.05, n=3). To further deﬁne
Fig. 2. Semi-quantitative RT-PCR of HttEx1 from HttEx1Q93 total RNA. (A) HttEx1Q93
product bands are detectable for larvae raised at both 23 °C and 29 °C. RNA for ribosomal
protein RP49 was used as an RNA baseline control. −H20 — water negative control,
−RP49 — RP49 negative PCR control, −P1/2 — HttEx1Q93 negative PCR control.
(B) Band density analysis indicates that animals raised at 29 °C show a signiﬁcantly
greater level of transgene expression than those raised at 23 °C (⁎pb0.05, n=3 crosses).
Table 1
In vivo vesicle dynamics in larval peripheral nerve.
Average
velocity
Average
velocity (VS)
Maximum
velocity (VM)
Stalls
(/region)
Circulatory
motion
(μm s−1) (μm s−1) (μm s−1) (/region)
OreR 0.93±0.02 0.87+0.03 1.11±0.04 1.08±0.39 0.25±0.12
20Q 0.89±0.04 0.82+0.04 1.06±0.07 1.33±0.28 0.75±0.22⁎
93Q 0.93±0.04 0.79±0.03† 1.13±0.06 2.75±0.54⁎ 0.83±0.27⁎
4 separate nerve regions were analysed from each of 3 larvae, and 5 vesicles analysed
within each region. Average velocity includes travel in anterograde and retrograde
directions and excludes stalls. VS is the average velocity for all vesicles and includes
stalling events. VM is the maximum velocity for any vesicle in each region. Stalls were
deﬁned as pauses in vesicle locomotion during which less that 0.2 μm was attained
within 1 s, and “circulatory motion” as local successive oscillatory changes in vesicle
direction. Errors indicate SEMs.
Signiﬁcance within a column (⁎) or row (†) is indicated (pb0.05, n=12 regions).
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EM48 immunoreactivity in HttEx1Q93 and HttEx1Q20 peripheral
nerves (Fig. S2), conﬁrming that LAg can span the 1–2 μmwidth of a
normal peripheral larval axon (Hurd and Saxton, 1996; Gunawardena
et al., 2003). We also analysed motor neuron cell bodies within the
ventral nerve cord by this method. Mainly nuclear EM48 immunor-
eactive aggregates are present in HttEx1Q93 larvae, but were not
found in control animals (Fig. S2). Analysis of nuclei by Hoechst
staining (Figs. S2J–L), no difference in the number of detectable
neuromuscular junctions (Fig. S3), and no signiﬁcant change in the
overall diameter of peripheral nerves (data not shown) across the
three genotypes, argues against cell loss in HttEx193Q versus
HttEx1Q20 ventral cord.
To compare HttEx1Q93 transgene mRNA levels at both raising
temperatures,weperformed semi-quantitative rtPCRon larval total RNA
(Fig. 2A). Analysis of the resultant HttEx1Q93 band, absent in controls,
indicates a signiﬁcant elevation in expression at 29 °C versus 23 °C
(Fig. 2B, pb0.05, n=3). HttEx1Q93 accumulation and aggregation may
thus be concentration dependent in Drosophila larval motor neuronFig. 3. In vivo axonal cargo accumulation in HttEx1Q93 expressing Drosophila. (A) Represent
immobilised HttEx1Q93 specimens show extensive axonal accumulation of vGFP ﬂuorescen
total vGFP accumulate area, quantiﬁed over a restricted region of peripheral nerve, reveals a p
at 29 °C. (C) Constant low level ﬂuorescence in HttEx1Q93 and controls raised at 23 °C. 6 laaxons, although other chronic effects of a higher raising temperature on
htt axonal localisation and/or aggregation state cannot be ruled out.
Expanded HttEx1 perturbs axonal transport in vivo
To assess whether axonal HttEx1Q93 accumulation and aggrega-
tion perturbs axonal transport within intact live Drosophila, we
utilised double transgenic HttEx1Q93 larvae that co-express a human
neuropeptide-Y-GFP fusion protein (vGFP) in motor neurons. Neuro-
peptide-Y is a fast axonal transport cargo (D'Hooge et al., 1990), and
vGFP is diffusely distributed in wild-type nerve but accumulates into
large deposits within the axon when transport is compromised in a
Drosophila model of tauopathies (Mudher et al., 2004). Whilst vGFP
accumulates are not visible inmutant htt larvae raised at 23 °C (Fig. 3C
and data not shown), the peripheral nerves inmutant htt larvae raised
at 29 °C show a 2-fold increase in total vGFP accumulate area relative
to HttEx1Q20 larvae (Figs. 3A, B, pb0.05, n=6).
To investigate the mechanism by which vGFP accumulates in
axons of HttEx1Q93 larvae, we analysed dynamic vesicle movement
along the peripheral nerves of intact anaesthetised larvae raised at
29 °C. We observed both continuously moving and stalling vesicles,
which pause for signiﬁcant time periods, in larval nerves (see Movies
M1, M2, and M3, Supplementary material). When stalling vesicles
are excluded from analysis, the average and maximum velocity of
uninterrupted vesicle transport along several separate regions of
nerve is not reduced upon HttEx1Q93 expression (Table 1). How-
ever, stalling of vGFP vesicles is signiﬁcantly increased in HttEx1Q93
nerves (Table 1, pb0.05, n=12 regions), and average velocity of all
vesicles, including stalling vesicles, is reduced in HttEx1Q93 nerves
(Table 1, pb0.05). A peculiar “circulatory” motion of vesicles,
involving repeated switches between anterograde and retrograde
movement, occurred more frequently in both mutant and wild-type
htt larvae relative to OreR controls (Table 1, p=0.08, n12 regions).ative vesicular neuropeptide-Y-GFP (vGFP) distribution in larval peripheral nerves. Live,
ce, whereas vGFP in control nerve is distributed diffusely. Scale bar — 5 μm. (B) Relative
rogressive increase in vGFP accumulationwith increasing polyQ length for larvae raised
rvae raised from a single cross were analysed for each genotype (⁎pb0.05).
Fig. 4. Developmental effects of HttEx1Q93 expression in Drosophila. (A) Number of
adult eclosures after pan-neuronal transgene expression at 29 °C. HttEx1Q93
expression is severely toxic, preventing development to adult of all but a few
specimens, whereas OreR and HttEx1Q20Q controls develop normally. (B) HttEx1Q93
animals raised at 23 °C develop normally into adults. (C) HttEx1Q93 expression in
motor neurons allows some larvae to reach adulthood but causes a developmental
delay. 6 pUAS transgenic males were crossed to 10 driver females in a single test cross
for each genotype.
Fig. 5. Locomotion deﬁcit in HttEx1Q93 expressing Drosophila larvae. (A) The number
of body wall contractions over 30 s before (unstressed baseline) and after acute heat
shock (HS) when raised at 23 °C. HttEx1Q93 animals complete fewer contractions than
controls after HS only. This was also observed for larvae raised at 29 °C (B). (C,D) The
number of lines crossed over a square grid for 30 s before and after acute HS. As for
contractions, HttEx1Q93 animals raised at 23 °C (C) and 29 °C (D) cross fewer lines than
controls after HS only. (E,F) Comparison of the relative post-HS locomotion deﬁcit in
HttEx1Q93 animals raised at 29 °C and 23 °C. 15 animals raised at 23 °C and 5 animals
raised at 29 °C were tested for each genotype. Statistically signiﬁcant differences
for relevant comparisons are indicated by stars ⁎pb0.05; ⁎⁎pb0.01; ⁎⁎⁎pb0.001.
Non-signiﬁcant, ns.
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described in detail in Supplementary material. These results
demonstrate that HttEx1Q93 expression disrupts axonal transport
in different ways: it increases retention of transport vesicles
(accumulates) in the axon, and promotes stalling of motile vesicles.
Neuronal function is impaired by pathogenic HttEx1
To assess whether HttEx1Q93 expression detrimentally affects
neuron function, mutant HttEx1 was expressed pan-neuronally
using the elav-GAL4 driver. Drosophila pupation and metamorphosis,
prior to emergence (eclosion) as a pharate adult, is a period of
intense physiological change and sensitivity to toxic insult. Previous
work indicates that pan-neuronal HttEx1Q93 toxicity in Drosophila
allows only 20–30% of embryos to eclose (Steffan et al., 2001;
Wolfgang et al., 2005). Similarly, in our hands, 20.9% of HttEx1Q93
larvae raised at 29 °C eclose as adults relative to HttEx1Q20 (Fig. 4A).
However, such a defect is not observed for HttEx1Q93 animals raised
at 23 °C (Fig. 4B). When expression is directed to motor neurons at
29 °C, 52.7% of HttEx1Q93 larvae eclose as adults relative to
HttEx1Q20, and development is delayed (Fig. 4C). Motor neuron-
speciﬁc HttEx1Q93 expression thus subtly impedes development to
adult eclosion, whereas HttEx1Q93 pan-neuronal expression more
severely perturbs this stage in a temperature-dependent manner.Heat shock unveils a behavioural phenotype in HttEx1Q93 larvae
In late L3-stage Drosophila larvae, body wall contraction capability
and locomotion provides a direct, quantiﬁable readout of motor
neuron function and behaviour. To quantify larval locomotion, we
used contraction and line-crossing assays as previously described
(Mudher et al., 2004). Surprisingly, HttEx1Q93 animals do not exhibit
a signiﬁcant reduction in contraction rate over 30 s when raised at
either 23 °C or 29 °C (Figs. 5A, B). We also quantiﬁed the total number
of lines crossed by each larva over a grid for 30 s, in a line-crossing
assay that gauges free crawling ability. As with the contractions assay,
HttEx1Q93 larvae raised at either temperature are not deﬁcient in this
line-crossing assay (Figs. 5C, D).
Although HD is a fully penetrant condition, environmental factors
are likely to contribute to variations in clinical disease presentation
(van Dellen et al., 2000; Wexler et al., 2004). Given that polyQ
expression and external heat stress synergise to promote neuronal
toxicity in C. elegans (Gidalevitz et al., 2006), we tested the effect of an
acute heat shock prior to locomotion tests. When raised at 23 °C or
29 °C, all genotypes display a signiﬁcant deﬁcit in contraction rate and
line-crossing ability following heat shock (Figs. 5A–D, pb0.01,
n=15). However, the performance of the mutant htt larvae after
heat shock in both assays is signiﬁcantly reduced compared to
HttEx1Q20 and OreR larvae when raised at 23 °C (Figs. 5A, B pb0.05,
n=15) or 29 °C (Figs. 5C, D pb0.05, n=5). Interestingly, the
393C. Sinadinos et al. / Neurobiology of Disease 34 (2009) 389–395performance of HttEx1Q93 larvae reared at 29 °C showed a trend
towards worse performance than HttEx1Q93 larvae reared at 23 °C
(Fig. 5E, p=0.08, 5F, p=0.13, n=5). Development to adult is normal
for mutant HttEx1 animals and control animals exposed to acute heat
shock (Fig. S4), arguing against a general ﬁtness effect of heat shock on
vulnerable HttEx1Q93 maturation and behaviour. Heat shock there-
fore reveals a speciﬁc behavioural phenotype in HttEx1Q93 larvae
compared to HttEx1Q20 controls.
Discussion
We have shown that HttEx1Q93 expression perturbs axonal
transport and neuronal function in larval Drosophila motor neurons
in vivo. Axonal accumulation and aggregation of HttEx1Q93 correlates
with transport disruption, which involves increased stalling and
accumulation of GFP-labelled neuropeptide-Y transport vesicles. Our
study is the ﬁrst to perform such measurements in living animals
using real-time analysis in an in vivo model of HD. Despite the
transport impediment, we show that motor neuron-dependent larval
locomotion appears normal unless animals are heat stressed prior to
testing, which unveils a speciﬁc locomotor defect in mutant larvae. In
vivo transport perturbation by pathogenic HttEx1 is thus one process
by which pathogenic HttEx1 may weaken neuronal defences to
external stress during HD pathology.
Although expressed and aggregated in the cell body, N-terminal
htt-polyQ fragments (Li et al., 1999; Lee et al., 2004) or full length htt
(Li et al., 2001) accumulate within axons in HD and in animal models.
We show that axonal HttEx1Q93 EM48-immunoreactive aggregates
(Figs. 1A–E; S2) can exceed the previously observed normal diameter
of peripheral nerve axons (Hurd and Saxton, 1996). Observations of
swollen peripheral nerves and retention of axonal transport cargoes
has been reported in other polyQ Drosophilamodels (Gunawardena et
al., 2003). As suggested previously, pathogenic polyQ containing
proteins could disrupt axonal transport either by producing space-
occupying aggregates within axons that physically impair transport,
or by sequestering and/or interacting abnormally with various
proteins involved in axonal transport (Gunawardena and Goldstein,
2005). Insoluble IBs isolated from human HD brain tissue are enriched
for such proteins (Trushina et al., 2004), and transport cargo
accumulation in expanded HttEx1Q93 Drosophila larval nerve is
worsened by genetic reduction of motor proteins such as kinesin and
dynein (Gunawardena et al., 2003). Transport disruption by N-
terminal htt fragments could thus perturb axonal transport without
microscopically visible aggregation. This has recently been shown in
cell culture studies where expression of mutant HttEx1 results in
mitochondrial transport defects in the absence of obvious aggregate
formation (Orr et al., 2008). Interestingly, pan-neuronal Htt-full-
length-Q128 expression in Drosophila did not result in detectable
aggregation or transport cargo accumulation within the larval
peripheral nerves (Romero et al., 2008).
Our novel approach to visualize real-time axonal transport in living
intact larvae shows that continuously moving GFP-tagged vesicles
travel along HttEx1Q93 nerve at a velocity of 0.93±0.04 μm/s (Table
1), consistent with the lower limit of fast axonal transport (Brown,
2003). This value contrasts with an acute 25–30% reduction in
transport vesicle velocities following perfusion of pathogenic N-
terminal htt fragments over isolated squid axoplasm (Szebenyi et al.,
2003). This discrepancy with our ﬁndings could be due to our
exclusion of stalling vesicles in our calculations of average velocity.
When such vesicles were included in our velocity calculation in
addition to the continuously moving GFP-tagged vesicles, the average
velocity was signiﬁcantly reduced in HttEx1Q93 nerve to 0.79 μm/s,
which was not the case for OreR or HttEx1Q20 control nerve (Table 1).
These results highlight the importance of stalling events: more
stalling events were observed in HttEx1Q93 nerve (Table 1), and
this is in agreement with an increase in ‘stop-go’ vesicular motiondetected in axons of cultured primary striatal neurons derived from
Htt-FLQ72 knock-in mice (Trushina et al., 2004). It is possible that
GFP-tagged vesicles detach from fully active motor proteins during
stalling, particularly if there is a total motor protein deﬁcit due to local
sequestration to htt aggregates, and thus excessive competition with
other fast axonal transport cargoes in HttEx1Q93 axon. Consistent
with this notion, GFP-tagged vesicles accumulate in the motor axon
upon HttEx1Q93 expression (Figs. 3A, B).
Accumulation of GFP-tagged vesicles has been reported in a Dro-
sophila model of Tauopathies, following the expression of human tau
(Mudher et al., 2004). Despite axonal transport alterations in this tau
model, the larval neuromuscular junctions (NMJs) were present and
no cell loss in the ventral cord was detected, suggesting that these
transport defects are not a consequence of neuronal loss (Mudher et
al., 2004). Analysis of NMJs in mutant HttEx1 versus HttEx1Q20 larvae
revealed no difference (Fig. S3), suggesting that the axonal transport
disruption in mutant htt larvae is not a consequence of neuronal cell
death (with associated NMJ loss), but rather a consequence of
neuronal dysfunction. It is possible that the axonal transport defects
that we observe could be due to nuclear events (such as abnormal
transcription), as HttEx1Q93 aggregates were also found in the motor
neuron nuclei (Fig. S2). Interestingly, a reversible defect in retrograde
axonal transport was found to correlate with androgen receptor-polyQ
(AR-97Q) nuclear aggregate formation and reduced expression of
dynactin-1 in a mouse model of spinal and bulbar muscular atrophy
(Katsuno et al., 2006). This is consistent with transport being affected
by pathological changes in the nucleus. When perfused over isolated
squid axoplasm in vitro, however, pathogenic AR-57Q also reduced
axonal transport vesicle velocity in a similar manner to N-terminal htt
(Szebenyi et al., 2003), suggesting a direct interference of transport in
the axon. This was more recently attributed to an alteration in
regulatory signalling pathways on axonal transport by soluble AR-57Q
(Morﬁni et al., 2006). Perturbation of axonal transport may be a
common pathogenic mechanism amongst polyQ disorders, as axonal
aggregation of spinocerebellar ataxia 3 protein with a pathogenic
polyQ tract (SCA3-78Q) in Drosophila larval motor neurons was
associated with defective axonal transport of vesicular cargoes
(Gunawardena et al., 2003), although this was concurrent with
extensive motor neuron cell death and other work has shown that
SCA3-78Q is prone to nuclear aggregation rather than accumulation in
the axon to disrupt transport in this model (Lee et al., 2004).
Despite previous work showing that defective axonal transport in
Drosophila motor neurons can perturb larval motor neuron function
and locomotion (Hurd and Saxton, 1996; Mudher et al., 2004),
HttEx1Q93 larvae do not show defective locomotion under normal
environmental conditions, even if they are reared at high temperature
(29 °C). This could be due to compensatory cellularmechanisms in the
axonal compartment. Individuals with genetically equivalent htt-
polyQ expansions show considerable variation in their neuropatho-
logical manifestation of HD and environmental factors are showing an
emerging clinical signiﬁcance in HD pathology (Wexler et al., 2004).
Furthermore, environmental stress can inﬂuence pathology in HD
rodent and C. elegans models (van Dellen et al., 2000). One
environmental stress with relevance to protein conformational
disorders is heat shock: work with temperature-sensitive mutants in
C. elegans demonstrated that htt-polyQ misfolding synergises with
heat shock to perturb the function of ‘metastable’ proteins in the
neuron (Gidalevitz et al., 2006). Hence, we applied stress in the form
of heat shock prior to locomotion assays and found that prior acute
heat shock uncovers a defective locomotor phenotype in mutant
larvae. These ﬁndings demonstrate that protein misfolding and
aggregation, due to expression of mutant HttEx1Q93, sensitises
neurons to external stressful stimuli in vivo, unveiling behavioural
phenotypes that would not otherwise be apparent.
A molecular dissection of neuropathology in this Drosophilamodel
could reveal how axonal transport fails in HD. Furthermore, this model
394 C. Sinadinos et al. / Neurobiology of Disease 34 (2009) 389–395will allow exploration of how intrinsic htt-polyQ and extrinsic
environmental pressures converge to override various cellular protec-
tion mechanisms and perturb essential aspects of neuronal function,
giving rise to functional deﬁcits observed in the human condition.
Materials and methods
Drosophila genetics
Transgenic expression of Htt-polyQ was directed to Drosophila
melanogastermotor neurons via use of the pUAS-GAL4 system (Brand
and Perrimon, 1993). Male ﬂies homozygous for UAS-Htt-exon1-93Q,
or UAS-Htt-exon1-20Q control, were crossed to neuropeptide-Y
(vGFP) and D42 driver (vGFP∙D42) homozygous female virgins, as
described previously (Mudher et al., 2004). Oregon R homozygous
males not carrying a pUAS insert were crossed to vGFP∙D42 virgins as a
driver control (OreR). UAS lines were also crossed to elav pan-
neuronal driver female virgins. F1 L3-stage larvae were selected by
size and wandering behaviour for analysis. Crosses were raised at
23 °C or 29 °C on a standard medium of corn meal, yeast and agar
(Mudher et al., 2004).
Immunohistochemistry and Hoechst analysis
L3 larvae were dissected with a microdissection apparatus (Fine
Science Tools, Interfocus, UK) under a WM light microscope (Heer-
berg, Switz.) in ice-cold Drosophila saline to reveal nervous tissue.
Dissected preparations (‘skins’) were ﬁxed in 4% paraformaldehyde
for 90 min, before a 10 min wash in PBS containing 0.1% tween (0.1%
tPBS). Skins were incubated for 30 min in 2 N HCl prior to 4 washes in
tPBS. Skins were blocked for 30 min (30 μl/ml horse serum in 0.1%
tPBS) before incubation in the primary antibody solution (S830,
1:2000; EM48, 1:100, Calbiochem; anti-HRP, 1:1000, MP Biochem-
icals) for 24 h at 4 °C. Skins were washed 4 times in 0.1% tPBS, re-
incubated in secondary antibody (1:10,000) for 24 h at 4 °C, washed
for 4×10min in 0.1% tPBS and 5min in PBS, mounted on glass slides in
Vectashield ﬂuorescence mount (Vector Laboratories, CA, US), and
analysed at ×63 on a Zeiss Axioplan2 Epiﬂuorescence or Confocal
Microscope. Accumulate sizes and peripheral nerve diameters were
calculated in Metamorph software (Molecular Devices, CA, USA). The
term “aggregate” is used to describe S830 or EM48 immuno-positive
structures detectable by light microscopy and encompasses what has
been described by others as micro or macro aggregates and/or
inclusion bodies. Aggregates were further deﬁned by the following
criteria: The diameter of circular and non-circular htt immunoreactive
aggregates was measured as the largest cross sectional area. Across
our analysis, aggregates fell into two groups. Small aggregates (SAg)
measured from 0.7 μm to 1.3 μm in diameter, whereas large aggregates
(LAg) were equal to or exceeded 1.3 μm in diameter. For Hoechst
chromatin staining, skins were incubated in 1 μg/μl Hoechst in tPBS
for 20 min prior to the ﬁnal PBS wash.
RNA extraction and RT-PCR
For each experiment, 15 HttEx1Q93 larvae, driven with D42-GAL4,
were homogenised with Trizol reagent (Invitrogen) to isolate total
RNA. RNA was reverse transcribed with iScript cDNA synthesis kit
(Biorad). PCR was carried out with HotStar Taq hot start DNA
polymerase (Qiagen). HttEx1— speciﬁc primers were P1 (5′-TGGCCG-
ACCCTGGAAAAGCTG-3′) and P2 (5′-TGAGGCAGCAGCGGCTGTGC-3′),
annealing at 68 °C. RP49 was used as an RNA loading control, as
described previously (Tsichritzis et al., 2007). For densitometry
analysis, product bands from each of 3 different HttEx1 PCR cycle
numbers were expressed as a ratio of RP49 expression, and the
average of these ratios used for comparison between 23 °C and 29 °C
HttEx1 expression levels.In vivo axonal transport analysis
Axonal transport analysis was conducted as previously described
(Mudher et al., 2004). Drosophila L3 larvae were anaesthetised in
diethylether vapour for 10min, immobilised in 1% agarose ventral face
up on glass slides, and mounted under coverslips at pressure for
analysis. For total accumulate area acquisition, peripheral nerves were
analysed between the 2nd and 4th dentical bands. vGFP accumulates
were imaged at ×63 on a Axioplan2 Epiﬂuorescence Microscope
(Zeiss), and thresholded in Metamorph software (Molecular Devices,
CA, USA). Movies of vesicular movement at separate regions of
peripheral nerve were captured at ×100 magniﬁcation and vesicular
movement tracked in Metamorph as previously described (Mudher
et al., 2004).
Developmental-, larval locomotion- and statistical analysis
For developmental analysis, single transgenic crosses were
established simultaneously with age-matched virgin females. Parents
were removed 7d after cross initiation and eclosing adults scored and
removed from test vials daily. Line-crossing and contraction tests were
conducted as previously described (Mudher et al., 2004). Tests were
conducted on a 1 mm bed of 1% agarose in standard Drosophila saline.
For both tests, larvae were allowed to acclimatise to the testing area
for 2 min prior to testing. In the line-crossing assay, the number of
lines crossed on a 20×20 square grid (10 cm×10 cm), with the larva
starting at the grid's middle point, was counted over 30 s. In the
contractions assay, full peristaltic body wall contractions were
quantiﬁed over 30 s on 1% agarose. For heat shock prior to locomotion
tests, larvae were housed individually in plastic Eppendorf vials and
incubated at 39 °C for 5 min, before transfer to 1% agarose plates at
room temperature for a 1 min cooling period (3 min total) and testing
for locomotion ability as described above. For statistical analyses, the
unpaired Student's t-test was used in Microsoft Excel.
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